Mary Rinella

25PUBLICATIONS

95CO-AUTHORS

Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Palliative careRegenerative medicine (incl. stem cells)Sport and exercise nutritionMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 30, 2026

The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.

|Jun 19, 2026

The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

|Mar 19, 2026

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.

Mary E Rinella, Silvia Sookoian

|Jan 22, 2026

Response to "Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease".

Tsubasa Tsutsumi, Michael R Charlton, Takumi Kawaguchi

|Jan 07, 2026

MASLD as a complication of obesity must include liver risk stratification.

Mary E Rinella, Arun J Sanyal, Rohit Loomba

|Oct 23, 2025

Practical Considerations for the Use of Semaglutide in MASH.

Matthew A Odenwald, Mary E Rinella

Pageof 5

Frequent Collaborators

Rohit Loomba

Jeffrey V Lazarus

Aleksander Krag

Brent Neuschwander-Tetri

Norah Terrault

Manal F Abdelmalek

Arun J Sanyal

Jörn M Schattenberg

Vincent Wai-Sun Wong

Emmanuel A Tsochatzis

Frequent Collaborators

Rohit Loomba

Jeffrey V Lazarus

Aleksander Krag

Brent Neuschwander-Tetri